Yale News has published a feature on Yale Ventures and its expanding portfolio of accelerator funds — spotlighting the Colton Center for Autoimmunity at Yale as one of five funds helping faculty translate research into real-world impact. The article highlights how Yale Ventures, which manages more than $1 billion in annual university research output, is building structured pathways to help faculty navigate the complex journey from laboratory discovery to commercial application.
The Colton Center for Autoimmunity at Yale is featured as one of three established accelerator funds alongside the Blavatnik Fund for Innovation (life sciences) and the Roberts Innovation Fund (engineering). Together with two newer funds — HealthTech Works and the Planetary Solutions Impact Accelerator — they form Yale Ventures’ core portfolio of innovation programs. Each fund provides faculty not only with targeted grant funding, but also with entrepreneurship training, access to industry networks, and hands-on business support from Yale Ventures’ team of venture development professionals.
The article notes that since its launch in 2020, the Colton Center has supported 49 projects with more than $5 million in funding — backing research across autoimmune and allergic diseases with a clear focus on commercialization potential. Scientific Director Dr. Joseph Craft and Director Makoto Yoshioka are cited as leading the center’s work within Yale Ventures’ broader innovation ecosystem.
The feature underscores the Colton Center’s growing role not just as a research funder, but as a bridge between academic immunology and the startup and licensing ecosystem.
Featured Experts
Joseph Craft, MD
Director, Colton Center for Autoimmunity (Yale University)
Departments of Internal Medicine (Rheumatology, Allergy & Immunology) & Immunobiology, Yale School of Medicine, Yale University
Makoto Yoshioka, PhD
Operational Director, Colton Center for Autoimmunity (Yale University)
Yale Ventures / Yale School of Medicine, Yale UniversityRelated News
Yale Receives $2.5M Gift to Advance Autoimmune Research
A $2.5 million gift from the Colton Foundation will advance autoimmune research at Yale School of Medicine and strengthen collaboration across the Colton Consortium for Autoimmunity's four member institutions.
Yale News Spotlights the Colton Center as a Key Driver of Autoimmune Innovation at Yale Ventures
A Yale News feature on Yale Ventures' five accelerator funds highlights the Colton Center for Autoimmunity's growing role in translating autoimmune research into startups, licenses, and real-world therapies.
Yale Researchers Use Machine Learning Tool to Improve Personalized Immunotherapy Design
A Colton-supported Yale study has produced ImmunoStruct, a machine learning model that improves personalized cancer vaccine design by incorporating the 3D structure of immune-activating peptides — now licensed to a Yale spinout.